Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded up 58.8% during mid-day trading on Thursday . The stock traded as high as C$0.15 and last traded at C$0.14. 2,646,987 shares changed hands during trading, an increase of 1,242% from the average session volume of 197,312 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Price Performance
The company’s fifty day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.13. The stock has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- Expert Stock Trading Psychology Tips
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- How to invest in marijuana stocks in 7 steps
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
